£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days · 19 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 07 August 2026 12 August 2026 16 August 2026 21 August 2026
View at Amazon ↗

Price data last checked 72 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £490 Days at Price

Price Analysis

Most common price: £490 (19 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 19 days

Description

This comprehensive study provides a detailed outlook for uterine cancer therapeutics and diagnostics within the United States from 2023 to 2028. By analyzing latent demand, also known as potential industry earnings (P.I.E.), this report offers critical data across 10,833 US zip codes. Users can access specific estimates in millions of U.S. dollars for each zip code, alongside comparative benchmarks that show the percent share of each location relative to its state and the nation as a whole. This statistical approach assists professionals in gauging specific zip codes against others, making it a practical tool for sales and distribution strategy planning.

Key Features

Provides latent demand outlooks for uterine cancer therapeutics and diagnostics through 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Covers detailed data across 10,833 specific zip codes throughout the United States.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the US.

Supports sales and distribution planning through granular statistical analysis of US zip codes.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
99% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 17 Sep 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
99% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 25 Aug 2026
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
98% match

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

£795.00 25 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 20 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Aug 2026
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
98% match

The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics

Price unavailable
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
98% match

The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics

Price unavailable
The 2023-2028 Outlook for Endometrial Cancer Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Endometrial Cancer Treatments for US Zip Codes

£490.00 22 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
97% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
97% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
Cervical Cancer Treatment Outlook 2023-2028 US Zip Codes
97% match

Cervical Cancer Treatment Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City
97% match

The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City

£795.00 30 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
97% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 03 Oct 2026
Endometrial Cancer Treatments Outlook Japan 2023-2028
97% match

Endometrial Cancer Treatments Outlook Japan 2023-2028

£495.00 22 Oct 2026
Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study
97% match

Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study

£490.00 26 Aug 2026
The 2023-2028 Outlook for Gynecologic Oncology in the United States
96% match

The 2023-2028 Outlook for Gynecologic Oncology in the United States

£520.00 28 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in Japan
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in Japan

£495.00 16 Aug 2026
The 2023-2028 Outlook for Cancer Screenings in China
96% match

The 2023-2028 Outlook for Cancer Screenings in China

£495.00 29 Oct 2026
The 2023-2028 Outlook for Cancer Screenings in Japan
96% match

The 2023-2028 Outlook for Cancer Screenings in Japan

£495.00 20 Aug 2026
Basal Cell Carcinoma Surgery Outlook 2023-2028 US Report
96% match

Basal Cell Carcinoma Surgery Outlook 2023-2028 US Report

£490.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
2023-2028 Endometrial Cancer Treatments Outlook - China
96% match

2023-2028 Endometrial Cancer Treatments Outlook - China

£495.00 22 Oct 2026